Michael Dorrington

Michael Dorrington

Consultant / Advisor chez Ontario Genomics Institute (Private Equity)

Consumer Services
Finance

Profil

Dr. Michael Dorrington joined Ontario Genomics in 2020.
In his current role, he supports the implementation of strategic initiatives to bring new genomic-derived solutions to Ontario’s key sectors.
Mike helps build effective relationships by connecting, enabling and working with leading academics and diverse partners and partner organizations to advance collaborative investment opportunities.
He is the main point of contact for several funded projects.
Before joining Ontario Genomics, Mike was a post-doctoral fellow in the Laboratory of Immune System Biology at the National Institute of Allergy & Infectious Diseases outside of Washington, DC.
In this position, he studied the many roles of antiviral cytokines in inflammation and antibacterial immune responses using cutting-edge genomic and transcriptomic technologies.
He was also a post-doctoral representative to the NIH’s Immunology Interest Group.
Mike has a Ph.D.
in Infection & Immunity from McMaster University and a B.Sc.
in Life Sciences from the University of British Columbia.
During his Ph.
D., he held the Canadian Thoracic Society/Canadian Lung Association Doctoral Studentship for which he helped develop novel mouse models of bacterial infection.

Postes actifs de Michael Dorrington

SociétésPosteDébut
Consultant / Advisor 01/08/2020
Tous les postes actifs de Michael Dorrington

Formation de Michael Dorrington

McMaster University Doctorate Degree
University of British Columbia Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Michael Dorrington

Relations

100 +

Relations au 1er degré

3

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées1

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Michael Dorrington
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT